Fresenius traded at 32.20 this Friday May 20th, increasing 0.41 or 1.29 percent since the previous trading session. Looking back, over the last four weeks, Fresenius gained 8.00 percent. Over the last 12 months, its price fell by 30.48 percent. Looking ahead, we forecast Fresenius to be priced at 32.99 by the end of this quarter and at 29.75 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
32.20
Daily Change
1.29%
Yearly
-30.48%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Akzo Nobel 80.92 1.84 2.33% -22.90%
Alcon AG 70.74 1.22 1.75% 14.54%
AstraZeneca 10,466.00 216.00 2.11% 28.65%
BASF 49.58 0.72 1.47% -26.92%
Bayer 64.19 0.79 1.25% 14.65%
Beiersdorf 93.72 0.56 0.60% -4.00%
DSM 138.15 1.50 1.10% -7.31%
DaVita Healthcare Partners 94.18 -0.44 -0.47% -23.47%
Essilor 147.35 1.70 1.17% 3.40%
E.ON 10.17 0.21 2.10% -0.19%
Fresenius Medical Care 56.40 0.58 1.04% -15.62%
Fresenius Medical Care 29.98 -0.02 -0.07% -25.90%
Fresenius 32.20 0.41 1.29% -30.48%
Getinge 286.30 1.40 0.49% -0.38%
Givaudan 3,521.00 42.00 1.21% -11.00%
GN Store Nord 236.80 5.20 2.25% -52.98%
GRIFOLS 19.71 -0.20 -1.00% -15.41%
GlaxoSmithKline 1,757.20 25.60 1.48% 29.68%
Hikma Pharmaceutical 1,744.50 41.00 2.41% -29.00%
Lonza Group 553.40 19.60 3.67% -2.54%
Merck 173.55 5.85 3.49% 18.18%
Novartis 86.68 0.99 1.16% 9.49%
Philips 23.59 0.40 1.70% -49.66%
Roche Holding 318.20 1.30 0.41% 3.31%
RWE 43.74 1.27 2.99% 34.09%
Sanofi 102.18 2.12 2.12% 15.81%
Smith & Nephew PLC 1,283.47 25.47 2.02% -17.41%
William Demant Holding 288.30 4.40 1.55% -5.63%

Indexes Price Day Year
DE40 14097 215.06 1.55% -8.68%
EU50 3688 47.46 1.30% -8.39%

Fresenius
Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.